Parainfluenza virus 3 pneumonia in a kidney transplant recipient.
We report the first case of parainfluenza virus type 3 (PIV3) pneumonia in a kidney transplant recipient. A 39-year-old man developed pneumonia during hospitalization 6 years after kidney transplantation. He became hypoxic and underwent noninvasive ventilation. PIV3 was detected in the bronchoalveolar lavage fluid. He was treated successfully with aerosolized ribavirin and intravenous immunoglobulin. Although he recovered from pneumonia, his graft function deteriorated and he had to restart peritoneal dialysis.
Park
S Y
SY
Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Sung
H
H
Park
K T
KT
Kim
S C
SC
Kim
S-H
SH
Choi
S-H
SH
Kim
Y S
YS
Woo
J H
JH
Lee
S-O
SO
Han
D J
DJ
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D001992:Bronchoalveolar Lavage Fluid / Q000821:virology; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D010224:Parainfluenza Virus 3, Human / Q000302:isolation & purification*; D011024:Pneumonia, Viral / Q000175:diagnosis / Q000188:drug therapy / Q000821:virology; D010253:Respirovirus Infections / Q000175:diagnosis / Q000188:drug therapy / Q000821:virology; D012254:Ribavirin / Q000627:therapeutic use; D016896:Treatment Outcome
D000998:Antiviral Agents; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D012254:Ribavirin